NASDAQ: HQYHealthequity Inc Stock
$98.88+1.21 (+1.24%)
Updated Jul 20, 2026
HQY Price
$98.88
Fair Value Price
N/A
Market Cap
$8.27B
52 Week Low
$72.76
52 Week High
$105.96
P/E
36.76x
P/B
4.04x
P/S
5.18x
PEG
1.35x
Dividend Yield
N/A
Revenue
$1.34B
Earnings
$230.70M
Gross Margin
70.7%
Operating Margin
26.45%
Profit Margin
17.3%
Debt to Equity
0.62
Operating Cash Flow
$490M
Beta
0.67
Next Earnings
Sep 1, 2026
Ex-Dividend
N/A
Next Dividend
N/A
HQY Overview
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HQY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
HQY
Ranked#10 of 41
Ranked#10 of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $45.22 | A | |
| $6.51 | A | |
| $70.50 | B |
Be the first to know about important HQY news, forecast changes, insider trades & much more!
HQY News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HQY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HQY ($98.88) is trading above its intrinsic value of $38.02, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HQY is poor value based on its earnings relative to its share price (36.76x), compared to the US market average (11.71x)
P/E vs Market Valuation
HQY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more HQY due diligence checks available for Premium users.
Valuation
HQY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
36.76x
Industry
12.42x
Market
11.71x
HQY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HQY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
HQY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.04x
Industry
3.39x
HQY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HQY price to earnings growth (PEG)
For valuing profitable companies with growth potential
HQY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
HQY's financial health
Profit margin
Revenue
$354.6M
Net Income
$69.4M
Profit Margin
19.6%
HQY's Earnings (EBIT) of $353.75M... subscribe to Premium to read more.
Interest Coverage Financials
HQY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.3B
Liabilities
$1.3B
Debt to equity
0.62
HQY's short-term assets ($466.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HQY's long-term liabilities ($1.12B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HQY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HQY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$97.5M
Investing
-$13.9M
Financing
-$137.2M
HQY's operating cash flow ($489.88M)... subscribe to Premium to read more.
Debt Coverage Financials
HQY vs Health Information Service Stocks
Healthequity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.